Impact of Tobacco Smoke and Nicotine Exposure on Lung Development

Kevin Gibbs1, Joseph M Collaco2, Sharon A McGrath-Morrow2

  • 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD.

Chest
|October 27, 2015
PubMed

Insights

Prenatal and postnatal tobacco and nicotine exposure harms lung development and immune responses in children, increasing risks for asthma and infections. Recent research highlights genetic and epigenetic factors influencing these long-term respiratory health outcomes.

Area of Science:

  • Pediatric Respiratory Medicine
  • Environmental Health Sciences
  • Developmental Toxicology

Background:

  • Prenatal and postnatal exposure to tobacco smoke and nicotine negatively impacts lung development and immune function.
  • This exposure is linked to increased wheezing, viral infection susceptibility, and asthma symptoms in children.
  • Approximately 10% of US pregnancies involve in utero tobacco/nicotine exposure, posing significant health risks to neonates.

Purpose of the Study:

  • To review recent discoveries (last 5 years) on lung development and tobacco/nicotine exposure.
  • To focus on the impact of prenatal exposure on lung development, particularly nicotinic acetylcholine receptors.
  • To examine the association between exposure and augmented infection risk, immune skewing, and allergic phenotypes.

Main Methods:

  • Review of recent scientific literature (last 5 years) on tobacco/nicotine exposure and lung development.
  • Analysis of studies investigating effects on respiratory function, immune response, and asthma development.
  • Examination of genomic and epigenetic factors influencing long-term respiratory health.

Main Results:

  • Prenatal and postnatal exposure diminishes lung function and alters respiratory chemoreception in neonates.
  • Exposure is associated with a T-helper type 2 immune bias, increasing allergy and asthma risk.
  • Genomic and epigenetic factors, like DNA methylation changes, are identified as potential risk modifiers.

Conclusions:

  • Tobacco and nicotine exposure during critical developmental periods has lasting adverse effects on respiratory health.
  • Understanding genetic and epigenetic influences is crucial for mitigating risks associated with early-life exposure.
  • Secondhand smoke and nicotine exposure in childhood contribute to significant respiratory morbidities.

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.2K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K